Arpida raises CHF 51.3M

Infectious disease company Arpida (Basel, Switzerland) raised CHF 51.3 million ($39.4 million) in a series C round co-led by swissfirst and Temasek. Other investors included Carnegie Fund; CDIB Biosci...